Sirolimus balloon for heart artery blockages at branches
Part of Heart & circulation clinical trials.
This study tests a balloon coated with sirolimus (a medicine to prevent re-narrowing) to treat blockages in branch arteries of the heart. It may help patients who need a stent in the main artery but have a side branch that can be treated with this balloon instead of a stent.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 85 years old.
- You have a blockage in a heart artery that involves a side branch, and the side branch is at least 70% blocked.
- Your doctor plans to place a stent in the main artery and use a special balloon (without a stent) in the side branch.
- Your side branch artery is between 2.0 and 4.0 mm wide and the blockage is 40 mm or shorter.
- You do not have active bleeding, recent stroke, severe kidney disease, or other serious health issues that would make the procedure unsafe.
- You are willing to attend multiple follow-up visits and have an angiogram (X-ray of the arteries) at 9 months after the procedure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two ways to treat blockages where a heart artery splits into two branches: using special balloons that release medication versus placing stents (small metal tubes). The goal is to find the safest and most effective approach for patients with stable chest pain and proven heart blood-flow problems.
This trial compares two types of special balloons coated with different medications to treat blocked heart arteries in patients with acute heart attacks. The goal is to see which coating works better to keep the artery open and prevent future blockages.
This trial tests a new balloon coated with sirolimus (a drug that helps prevent re-blockage) for treating blocked arteries at branch points (bifurcations) in the heart. If you have a blocked artery at a branch point, this study may offer a way to treat the side branch without placing a stent there.
This trial studies a sirolimus drug-coated balloon to treat certain “forked” coronary artery blockages (bifurcation lesions). It aims to reduce re-narrowing of the artery and improve blood flow after the procedure.
This study tests a special balloon coated with a medicine (Biolimus) to open new blockages in large heart arteries. The goal is to see if it works well as an alternative to a stent for people with certain blockages.
This trial compares two ways to open a blocked artery that splits into two branches (a bifurcation): using a balloon coated with medicine (drug-coated balloon, or DCB) versus a drug-eluting stent (DES). The goal is to see which approach works better for patients with this type of blockage.
Hear when a new Coronary Bifurcation Lesion trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.